A Study of a Single Intravenous Infusion Dose of TAK-925 in Participants With Idiopathic Hypersomnia

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

January 26, 2020

Primary Completion Date

November 19, 2020

Study Completion Date

November 23, 2020

Conditions
Idiopathic Hypersomnia
Interventions
DRUG

TAK-925

TAK-925 IV infusion.

DRUG

TAK-925 Placebo

TAK-925 placebo-matching IV infusion.

Trial Locations (22)

20815

"Helene A. Emsellem, MD PC trading as The Center for Sleep & Wake Disorders", Chevy Chase

29201

Bogan Sleep Consultants, LLC, Columbia

30281

Global Research Associates, Stockbridge

30342

NeuroTrials Research, Inc., Atlanta

32216

Jacksonville Center for Clinical Research, Jacksonville

32789

Florida Pulmonary Research Institute, LLC, Winter Park

33009

MD Clinical, Hallandale

33024

Research Centers of America, Hollywood

33765

St Francis Medical Institute, Clearwater

34741

Pulmonary Disease Specialists, PA, d/b/a PDS Research, Kissimmee

35007

Wright Clinical Research, Alabaster

44195

The Cleveland Clinic Foundation, Cleveland

45212

CTI Clinical Trial and Consulting Services, Cincinnati

72211

Preferred Research Partners, Inc., Little Rock

78229

Sleep Therapy & Research Center, San Antonio

80301

Alpine Clinical Research Center, Boulder

80918

Delta Waves Sleep Disorders and Research Center, Colorado Springs

85306

Pulmonary Associates Clinical Trials, Glendale

92103

Pacific Research Network, Inc, San Diego

94063

Stanford School of Medicine, Redwood City

812-0025

SOUSEIKAI PS Clinic, Hakata-ku

130-0004

Sumida Hospital, Sumida-ku

All Listed Sponsors
lead

Millennium Pharmaceuticals, Inc.

INDUSTRY